Prot #AC-079A501: A PROspective, Observational, U.S.-based Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed with Mycosis Fungoides Cutaneous T-cell Lymphoma and Treated with Valchlor

Project: Research project

Project Details

StatusFinished
Effective start/end date3/6/15 → 3/6/19

Funding

  • DrugDev Inc. (Prot #AC-079A501 // Prot #AC-079A501)
  • Actelion Pharmaceuticals US, Inc. (Prot #AC-079A501 // Prot #AC-079A501)